Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-210-5 | CAS number: 117-80-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- July 23, 2014 - August 22, 2014
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 014
- Report date:
- 2014
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1200 (Acute Dermal Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- other: Japan MAFF Testing Guideline of 12 Nosan No. 8147 as this in line with OECD 402.
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Bioassay, Labor für biologische Analytik GmbH, Im Neuenheimer Feld 515-519, 69120 Heidelberg
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- Dichlone
- EC Number:
- 204-210-5
- EC Name:
- Dichlone
- Cas Number:
- 117-80-6
- Molecular formula:
- C10H4Cl2O2
- IUPAC Name:
- dichlone
- Details on test material:
- - Name of test material (as cited in study report): Dichlone
- Physical state: Solid/ yellow
- Storage condition of test material: Room temperature
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Wiga GmbH, Germany
- Age at study initiation: male animals approx. 8 weeks, female animals approx. 12 weeks
- Weight at study initiation: mean weights males: 230.8 g, females: 207.8g
- Housing: Single housing in Makrolon cages type III
- Diet: VRF1(P); SDS Special Diets Services, 67122 Altrip, Germany
- Water: Tap water ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22°C ± 3°C
- Humidity (%): 30 - 70 %
- Air changes (per hr): approx. 10
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: August 04, 2014 To: August 22, 2014
Administration / exposure
- Type of coverage:
- semiocclusive
- Vehicle:
- corn oil
- Details on dermal exposure:
- TEST SITE
- Area of exposure: dorsal and dorsolateral parts of the trunk
- % coverage: About 40 cm² (corresponds to at least 10% of the body surface)
- Type of wrap if used: The test item was covered with an air-permeable dressing (4 layers of absorbent gauze (Ph. Eur. supplied by Lohmann GmbH & Co., KG) and stretch bandage (Fixomull® Stretch (adhesive fleece) supplied by Beiersdorf AG).
REMOVAL OF TEST SUBSTANCE
- Washing (if done): rinsing of the application site with warm water
- Time after start of exposure: 24 h
TEST MATERIAL
- Constant concentration used: yes
- For solids, paste formed: no, suspension
VEHICLE
- Amount(s) applied (volume or weight with unit): 3.08 ml/kg bw
- Concentration (if solution): 65g/100 ml - Duration of exposure:
- 24 h
- Doses:
- 2000 mg/kg bodyweight
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of weighing: Individual body weights shortly before administration (day 0), weekly thereafter and on the last day of observation.
- Frequency of observation: Clinical signs for each animal were recorded several times on the day of administration and at least once during each workday thereafter.
- Necropsy of survivors performed: yes
- Other examinations performed: scoring of skin findings
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality occurred
- Clinical signs:
- No systemic clinical signs were observed during clinical examination with one exception in the male group. One male revealed impaired general state and piloerection on study day 1.
- Body weight:
- The mean body weight of the animals increased within the normal range throughout the study period with one exception in the female group. One female revealed stagnation of body weight during the first week, but the body weight was within the normal range during the second week.
- Gross pathology:
- No macroscopic pathologic abnormalities were noted in the animals (5 males and 5 females) examined on the last day of observation.
Any other information on results incl. tables
Local effects:
All male animals revealed severe erythema (grade 4) from day 1 until day 3. In one animal severe erythema persisted until day 7. In this animal the finding decreased to moderate erythema (grade 3) on day 8, to well-defined erythema (grade 2) from day 9 until day 10 and to very slight erythema (grade 1) on day 13. The other four animals showed well-defined erythema from day 6 until day 7 and very slight erythema from day 8 until day 10. All animals revealed slight edema (grade 2) on day 1, which increased to moderate edema (grade 3) on day 2 and 3. From day 6 until day 7 slight edema was noted again in all animals. Edema decreased to very slight edema (grade 1) in four out of five males from day 8 until day 10. Black discolored scaling and incrustations were noted additionally in three out of five males from day 6 until day 14. The two other males revealed black discolored scaling and incrustations from day 6 until day 7 or 8 and again from day 13 until day 14.
Four out of five females revealed moderate erythema from day 1 until day 3. The fifth female showed moderate erythema on day 1 and 3, but severe erythema (grade 4) on day 2. The findings decreased to well-defined erythema in 2 females from day 6 until day 7 or 10, respectively. In one of these females very slight erythema was seen from day 8 until day 10. In the other three animals very slight erythema was seen from day 6 until day 10. Four out of five females revealed slight edema from day 1 until day 3, while from day 6 until day 10 very slight edema was noted in these animals. The fifth female revealed slight edema on day 1 and 3 and moderate edema on day 2. From day 6 until day 10 very slight edema was observed in this animal. In three animals black discolored scaling was seen from day 6 until day 14, in another animal this finding was noted from day 13 until day 14 only.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the conditions of this study the median lethal dose (LD50) of Dichlone after dermal application was found to be greater than 2000 mg/kg bw in male and female rats.
- Executive summary:
In an GLP-compliant acute dermal toxicity study (Limit Test) following OECD guideline 402, young adult Wistar rats (5 males and 5 females) were dermally exposed to a single dose of 2000 mg/kg bw of Dichlone (as suspension in corn oil Ph.Eur.) to the clipped skin (dorsal and dorso-lateral parts of the trunk) and covered by semi-occlusive dressing for 24 hours. The application area comprised at least 10% of the total body surface area. The animals were observed for 14 days. Impaired general state and piloerection were recorded in one male on teh first day of the study only. No signs of systemic toxicity were observed in the other animals (four males, five females). No mortality occurred. The following test item-related local effects were recorded during the course of the study: very slight to severe erythema (grade 1 to 4), very slight to moderate edema (grade 1 to 3), black discolored scaling and black discolored incrustations. The local effects occurred during the whole study period (14 days). No macroscopic pathologic abnormalities were noted in all animals examined at the end of the study. The mean body weight of the animals increased within the normal range throughout the study period with one exception in the female group. One female revealed stagnation of body weight during the first week, but the body weight was within the normal range during the second week. No mortality occurred. Accordingly, the acute dermal median lethal dose (LD50) was determined to be LD50, dermal, rat > 2000 mg/kg bw
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.